合成路线1
该中间体在本合成路线中的序号:
(I) The condensation of 2,5-difluoronitrobenzene (I) with ethyl 2-amino-5-methylthiophene-3-carboxylate (II) by means of triethylamine in hot DMSO or 2-methoxyethanol giving ethyl 2-(4-fluoro-2-nitroanilino)-5-methylthiophene-3-carboxylate (III), which is reduced with H2 over Pd/C in ethanol to ethyl 2-(4-fluoro-2-aminoanilino)-5-methylthiophene-3-carboxylate (IV). The cyclization of (IV) by means of NaH in DMSO affords 9,10-dihydro-7-fluoro-2-methyl-4H-thieno[2,3b][1,5]benzodiazepin-2-one (V), which is finally condensed with N-methylpiperazine by means of TiCl4 in anisole at 120 C.
【1】
Chakrabarti, J.K.; Tupper, D.E.; Benzodiazepine derivatives. DE 2552403; FR 2292479; GB 1533235; JP 51076296 .
|
【2】
Pullar, I.A.; Chakrabarti, J.K.; Horsman, L.; Wright, F.C.; Tupper, D.E.; Hotten, T.M.; Heterooarenobenzodiazepines. 3. 4-Piperazinyl-10H-thieno[2,3-b][1,5]benzodiazepines as potential neuroleptics. J Med Chem 1980, 23, 8, 878-884.
|
【3】
Blancafort, P.; Castañer, J.; Serradell, M.N.; Flumezapine. Drugs Fut 1983, 8, 2, 110.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(II) |
35949 |
ethyl 2-amino-5-methyl-3-thiophenecarboxylate
|
|
C8H11NO2S |
详情 |
详情
|
(III) |
35950 |
ethyl 2-(5-fluoro-2-nitroanilino)-5-methyl-3-thiophenecarboxylate
|
|
C14H13FN2O4S |
详情 |
详情
|
(IV) |
35951 |
ethyl 2-(2-amino-5-fluoroanilino)-5-methyl-3-thiophenecarboxylate
|
|
C14H15FN2O2S |
详情 |
详情
|
(V) |
35952 |
7-fluoro-2-methyl-5,10-dihydro-4H-thieno[2,3-b][1,5]benzodiazepin-4-one
|
|
C12H9FN2OS |
详情 |
详情
|
(VI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(I) The title compound has been obtained by two related ways: Condensation of glycine ethyl ester (II) with 2,4-difluoronirobenzene (I) provided the N-arylglycine (III), which was further reduced to the phenylenediamine derivative (IV) by catalytic hydrogenation. Acylation of diamine (IV) with ethyl chloroglyoxylate, followed by ring closure in refluxing ethanol, yielded the quinoxalinedione (V). Subsequent electrophyllic nitration of (V) furnished the 6-nitroquinoxaline (VI). The fluoride group of (III) was then displaced with imidazole (VII) in hot DMF yielding the imidazolyl quinoxaline (VIII). Finally, basic hydrolysis of the ethyl ester function of (VIII) gave the target carboxylic acid.
【1】
Shishikura, J.; Inami, H.; Sakamoto, S.; Tsukamoto, S.; Sasamata, M.; Okada, M.; Fujii, M. (Yamanouchi Pharmaceutical Co., Ltd.); 1,2,3,4-Tetrahydroquinoxalindione deriv.. EP 0784054; US 6096743; WO 9610023 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(II) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(III) |
58528 |
ethyl 2-(5-fluoro-2-nitroanilino)acetate
|
|
C10H11FN2O4 |
详情 |
详情
|
(IV) |
58529 |
ethyl 2-(2-amino-5-fluoroanilino)acetate
|
|
C10H13FN2O2 |
详情 |
详情
|
(V) |
58530 |
ethyl 2-[7-fluoro-2,3-dioxo-3,4-dihydro-1(2H)-quinoxalinyl]acetate
|
|
C12H11FN2O4 |
详情 |
详情
|
(VI) |
58531 |
ethyl 2-[7-fluoro-6-nitro-2,3-dioxo-3,4-dihydro-1(2H)-quinoxalinyl]acetate
|
|
C12H10FN3O6 |
详情 |
详情
|
(VII) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(VIII) |
58532 |
ethyl 2-[7-(1H-imidazol-1-yl)-6-nitro-2,3-dioxo-3,4-dihydro-1(2H)-quinoxalinyl]acetate
|
|
C15H13N5O6 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(I) The intermediate arylpiperazine (VI) was prepared as follows: Reaction of 2,4-difluoronitrobenzene (I) with trifluoroethanol (II) in the presence of potassium tert-butoxide yielded the trifluoroethyl ether (III). After catalytic hydrogenation of the nitro group of (III), the resultant aniline (IV) was cyclized with bis(2-chloroethyl) amine hydrochloride (V) in a refluxing mixture of o-dichlorobenzene and n-hexanol to afford the target piperazine (VI).
【1】
Bantle, G.W.; Elworthy, T.R.; Guzman, A.; Jaime-Figueroa, S.; Lopez-Tapia, F.J.; Morgans, D.J. Jr.; Perez-Medrano, A.; Pfister, J.R.; Sjogren, E.B.; Talamas, F.X. (F. Hoffmann-La Roche AG); Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivs. as alpha1-adrenergic receptor antagonists. EP 0748800; JP 1997100269 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(II) |
19483 |
2,2,2-trifluoro-1-ethanol
|
75-89-8 |
C2H3F3O |
详情 | 详情
|
(III) |
54365 |
4-fluoro-1-nitro-2-(2,2,2-trifluoroethoxy)benzene; 5-fluoro-2-nitrophenyl 2,2,2-trifluoroethyl ether
|
|
C8H5F4NO3 |
详情 |
详情
|
(IV) |
54366 |
4-fluoro-2-(2,2,2-trifluoroethoxy)aniline; 4-fluoro-2-(2,2,2-trifluoroethoxy)phenylamine
|
|
C8H7F4NO |
详情 |
详情
|
(V) |
21583 |
2-chloro-N-(2-chloroethyl)-1-ethanamine; Bis(2-chloroethyl)amine; 1,1'-iminobis(2-chloroethane); N,N-bis(2-chloroethyl)amine
|
821-48-7 |
C4H9Cl2N |
详情 | 详情
|
(VI) |
54367 |
1-[4-fluoro-2-(2,2,2-trifluoroethoxy)phenyl]piperazine; 5-fluoro-2-(1-piperazinyl)phenyl 2,2,2-trifluoroethyl ether
|
|
C12H14F4N2O |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(I) Treatment of 2,4-difluoronitrobenzene (I) with isopropylamine in the presence of K2CO3 in THF afforded 2-isopropylamino-4-fluoronitrobenzene (II). Subsequent condensation of (II) with 2,3-difluorophenylacetonitrile (III) by means of potassium tert-butoxide, followed by oxidative treatment of the intermediate nitrile (IV) with H2O2 generated benzophenone (V). The nitro group of (V) was then reduced by hydrogenation over Raney Nickel yielding diamine (VI), which was cyclized to benzimidazole (VII) upon treatment with cyanogen bromide. Addition of the lithium anion of N-methyl-N-(trimethylsilyl)acetamide to (VII) gave beta-hydroxyamide (VIII). Finally, acid promoted dehydration of (VIII) furnished the corresponding alpha,beta-unsaturated amide.
【1】
Jungheim, L.N.; Shepherd, T.A.; Spitzer, W.A.; Tebbe, M.J. (Eli Lilly and Company); Anti-viral cpds.. EP 0906097; WO 9746237 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(II) |
37887 |
5-fluoro-N-isopropyl-2-nitroaniline; N-(5-fluoro-2-nitrophenyl)-N-isopropylamine
|
|
C9H11FN2O2 |
详情 |
详情
|
(III) |
37888 |
2-(2,3-difluorophenyl)acetonitrile
|
145689-34-5 |
C8H5F2N |
详情 | 详情
|
(IV) |
37889 |
2-(2,3-difluorophenyl)-2-[3-(isopropylamino)-4-nitrophenyl]acetonitrile
|
|
C17H15F2N3O2 |
详情 |
详情
|
(V) |
37890 |
(2,3-difluorophenyl)[3-(isopropylamino)-4-nitrophenyl]methanone
|
|
C16H14F2N2O3 |
详情 |
详情
|
(VI) |
37891 |
[4-amino-3-(isopropylamino)phenyl](2,3-difluorophenyl)methanone
|
|
C16H16F2N2O |
详情 |
详情
|
(VII) |
37892 |
(2-amino-1-isopropyl-1H-benzimidazol-6-yl)(2,3-difluorophenyl)methanone
|
|
C17H15F2N3O |
详情 |
详情
|
(VIII) |
37894 |
3-(2-amino-1-isopropyl-1H-benzimidazol-6-yl)-3-(2,3-difluorophenyl)-3-hydroxy-N-methylpropanamide
|
|
C20H22F2N4O2 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(I) Treatment of 2,4-difluoronitrobenzene (I) with isopropylamine in the presence of K2CO3 in THF afforded 2-isopropylamino-4-fluoronitrobenzene (II). Subsequent condensation of (II) with 2,3-difluorophenylacetonitrile (III) by means of potassium tert-butoxide, followed by oxidative treatment of the intermediate nitrile (IV) with H2O2 generated benzophenone (V). The nitro group of (V) was then reduced by hydrogenation over Raney Nickel yielding diamine (VI), which was cyclized to benzimidazole (VII) upon treatment with cyanogen bromide. Addition of the lithium anion of bis(trimethylsilyl)acetamide to (VII) gave beta-hydroxyamide (VIII). Finally, acid promoted dehydration of (VIII) furnished the corresponding alpha,beta-unsaturated amide, which was isoalted as the hydrochloride salt.
【1】
Jungheim, L.N.; Shepherd, T.A.; Spitzer, W.A.; Tebbe, M.J. (Eli Lilly and Company); Anti-viral cpds.. EP 0906097; WO 9746237 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(II) |
37887 |
5-fluoro-N-isopropyl-2-nitroaniline; N-(5-fluoro-2-nitrophenyl)-N-isopropylamine
|
|
C9H11FN2O2 |
详情 |
详情
|
(III) |
37888 |
2-(2,3-difluorophenyl)acetonitrile
|
145689-34-5 |
C8H5F2N |
详情 | 详情
|
(IV) |
37889 |
2-(2,3-difluorophenyl)-2-[3-(isopropylamino)-4-nitrophenyl]acetonitrile
|
|
C17H15F2N3O2 |
详情 |
详情
|
(V) |
37890 |
(2,3-difluorophenyl)[3-(isopropylamino)-4-nitrophenyl]methanone
|
|
C16H14F2N2O3 |
详情 |
详情
|
(VI) |
37891 |
[4-amino-3-(isopropylamino)phenyl](2,3-difluorophenyl)methanone
|
|
C16H16F2N2O |
详情 |
详情
|
(VII) |
37892 |
(2-amino-1-isopropyl-1H-benzimidazol-6-yl)(2,3-difluorophenyl)methanone
|
|
C17H15F2N3O |
详情 |
详情
|
(VIII) |
37893 |
3-(2-amino-1-isopropyl-1H-benzimidazol-6-yl)-3-(2,3-difluorophenyl)-3-hydroxypropanamide
|
|
C19H20F2N4O2 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(I) Treatment of 2,4-difluoronitrobenzene (I) with cyclopentylamine (II) in the presence of K2CO3 in THF afforded 2-cyclopentylamino-4-fluoronitrobenzene (III). Subsequent condensation of (III) with 2-fluorophenylacetonitrile (IV) by means of potassium tert-butoxide, followed by oxidative treatment of the intermediate nitrile (V) with H2O2 generated benzophenone (VI). The nitro group of (VI) was then reduced by hydrogenation over Raney Nickel yielding diamine (VII), which was cyclized to benzimidazole (VIII) upon treatment with cyanogen bromide. Addition of the lithium anion of N-methyl-N-(trimethylsilyl)acetamide to (VIII) gave beta-hydroxyamide (IX). Finally, acid promoted dehydration of (IX) furnished the corresponding alpha,beta-unsaturated amide, whic was isolated as the hydrochloride salt.
【1】
Jungheim, L.N.; Shepherd, T.A.; Spitzer, W.A.; Tebbe, M.J. (Eli Lilly and Company); Anti-viral cpds.. EP 0906097; WO 9746237 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(II) |
28850 |
cyclopentanamine
|
1003-03-8 |
C5H11N |
详情 | 详情
|
(III) |
37895 |
N-cyclopentyl-N-(5-fluoro-2-nitrophenyl)amine; N-cyclopentyl-5-fluoro-2-nitroaniline
|
|
C11H13FN2O2 |
详情 |
详情
|
(IV) |
37888 |
2-(2,3-difluorophenyl)acetonitrile
|
145689-34-5 |
C8H5F2N |
详情 | 详情
|
(V) |
37896 |
2-[3-(cyclopentylamino)-4-nitrophenyl]-2-(2-fluorophenyl)acetonitrile
|
|
C19H18FN3O2 |
详情 |
详情
|
(VI) |
37897 |
[3-(cyclopentylamino)-4-nitrophenyl](2-fluorophenyl)methanone
|
|
C18H17FN2O3 |
详情 |
详情
|
(VII) |
37898 |
[4-amino-3-(cyclopentylamino)phenyl](2-fluorophenyl)methanone
|
|
C18H19FN2O |
详情 |
详情
|
(VIII) |
37899 |
(2-amino-1-cyclopentyl-1H-benzimidazol-6-yl)(2-fluorophenyl)methanone
|
|
C19H18FN3O |
详情 |
详情
|
(IX) |
37900 |
3-(2-amino-1-cyclopentyl-1H-benzimidazol-6-yl)-3-(2-fluorophenyl)-3-hydroxy-N-methylpropanamide
|
|
C22H25FN4O2 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(I) The condensation of 2,4-difluoronitrobenzene (I) with 2(S)-aminobutyric acid (II) by means of triethylamine in refluxing acetone gives 2(S)-(5-fluoro-2-nitrophenylamino)butyric acid (III), which is reductocyclized with H2 over Raney-Ni in methanol/acetic acid, yielding 3(S)-ethyl-6-fluoro-1,2,3,4-tetrahydroquinoxalin-2-one (IV). Finally, this compound is treated with isopropyl chloroformate (V) and 4-methylpyridine in dichloromethane.
【1】
Rosner, M.; Billhardt-Troughton, U.-M.; Kirsch, R.; Kleim, J.-P.; Meichsner, C.; Riess, G.; Winkler, I. (Aventis SA); Quinoxalines, process for their preparation, and their use. CA 2160859; DE 4437406; EP 0708093; JP 1996225544; US 5723461 .
|
【2】
Graul, A.; Castañer, J.; Rabasseda, X.; GW-420867X. Drugs Fut 2000, 25, 1, 24.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(II) |
32037 |
(2S)-2-aminobutyric acid
|
1492-24-6 |
C4H9NO2 |
详情 | 详情
|
(III) |
32038 |
(2S)-2-(5-fluoro-2-nitroanilino)butyric acid
|
|
C10H11FN2O4 |
详情 |
详情
|
(IV) |
32039 |
(3S)-3-ethyl-6-fluoro-3,4-dihydro-2(1H)-quinoxalinone
|
|
C10H11FN2O |
详情 |
详情
|
(V) |
26492 |
2-[(chlorocarbonyl)oxy]propane
|
108-23-6 |
C4H7ClO2 |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) The condensation of ethyl 2-aminobenzo[b]thiophene-3-carboxylate (I) with 2,4-difluoronitrobenzene (II) afforded the diaryl amine (III). The nitro group of (III) was then reduced to amine (IV) by catalytic hydrogenation over Pd/C. Then, cyclization of amino ester (IV) with N-methylpiperazine (V) using TiCl4 in hot anisole produced the target benzothienobenzodiazepine, which was finally isolated as the corresponding maleate salt.
【1】
Fujimura, M.; Horiuchi, H.; Tanaka, H.; Kohara, T.; Hashimoto, K.; Kimura, K.; Seio, K.; Yasumatsu, H. (Welfide Corporation); Fused thiophene cpds. and medicinal use thereof. EP 1016664; JP 2001072684; WO 9911647 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
46396 |
ethyl 2-amino-1-benzothiophene-3-carboxylate
|
|
C11H11NO2S |
详情 |
详情
|
(II) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(III) |
46397 |
ethyl 2-(5-fluoro-2-nitroanilino)-1-benzothiophene-3-carboxylate
|
|
C17H13FN2O4S |
详情 |
详情
|
(IV) |
46398 |
ethyl 2-(2-amino-5-fluoroanilino)-1-benzothiophene-3-carboxylate
|
|
C17H15FN2O2S |
详情 |
详情
|
(V) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(II) In a related procedure, the condensation of 2-aminobenzo[b]thiophene-3-carbonitrile (VI) with 2,4-difluoronitrobenzene (II) produced the diaryl amine (VII). Reduction of the nitro group of (VII) using sodium hydrosulfite yielded diamine (VIII). Subsequent cyclization of amino nitrile (VIII) upon acidic treatment gave rise to the tetracyclic system (IX). This was then treated with refluxing N-methylpiperazine (V) to provide the title compound.
【2】
Fujimura, M.; Horiuchi, H.; Tanaka, H.; Kohara, T.; Hashimoto, K.; Kimura, K.; Seio, K.; Yasumatsu, H. (Welfide Corporation); Fused thiophene cpds. and medicinal use thereof. EP 1016664; JP 2001072684; WO 9911647 .
|
【1】
Horiuchi, H.; Kimura, K.; Tanaka, H.; et al.; Y-931, a novel antipsychotic with potential anti-NRH (NMDA receptor-hypofunction) activity: Synthesis and structure-activity relationships of 6H-[1]benzothieno[2,3-b][1,5]benzodiazepines. 16th Int Symp Med Chem (Sept 18 2000, Bologna) 2000, Abst PB-128. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(V) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(VI) |
46399 |
2-amino-1-benzothiophene-3-carbonitrile
|
|
C9H6N2S |
详情 |
详情
|
(VII) |
46400 |
2-(5-fluoro-2-nitroanilino)-1-benzothiophene-3-carbonitrile
|
|
C15H8FN3O2S |
详情 |
详情
|
(VIII) |
46401 |
2-(2-amino-5-fluoroanilino)-1-benzothiophene-3-carbonitrile
|
|
C15H10FN3S |
详情 |
详情
|
(IX) |
46402 |
8-fluoro-6H-[1]benzothieno[2,3-b][1,5]benzodiazepin-12-ylamine; 8-fluoro-6H-[1]benzothieno[2,3-b][1,5]benzodiazepin-12-amine
|
|
C15H10FN3S |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(I)
【1】
Harada K, Nishino S, Hirotsu K, et aL. 2002. Process for producing 5-fluorooxyindole and for producing intermediate therefor. W0 2002006228 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(III) |
66755 |
methyl 5-fluoro-2-oxoindoline-3-carboxylate |
|
C10H8FNO3 |
详情 | 详情
|
(IV) |
60384 |
5-fluoro-1,3-dihydro-2H-indol-2-one
|
56341-41-4 |
C8H6FNO |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(I) Reaction of 2,4-difluoronitrobenzene (I) with liquid ammonia gives 5-fluoro-2-nitroaniline (IIa) , which by subsequent displacement of the remaining fluoride group with N-methylpiperazine (III) in the presence of Et3N in NMP at 100 °C provides the piperazinyl aniline (IV) . Alternatively, nitroaniline (IV) can be prepared by condensation of 5-chloro-2-nitroaniline (IIb) with N-methylpiperazine (III) in hot EtOH , ethylene glycol or aqueous NaCl, optionally in the presence of NaOH . Catalytic hydrogenation of nitroaniline (IV) over Pd/C in EtOH at 40-45 °C yields the phenyldiamine (V) , wh ich by condensa t ion with ethyl 3-ethoxy-3-iminopropionate hydrochloride (VI) at reflux produces benzimidazole (VII) . Cyclocondensation of ethyl ester (VII) with 2-amino-6-fluorobenzonitrile (VIII) by means of LiHMDS , KHMDS or t-BuOK in THF or toluene furnishes dovitinib (IX ) , which is finally treated with racemic lactic acid in EtOH/H2O .
【1】
Machajewski, T., Shafer, C., McCrea, B. et al. (Novartis Vaccines and Diagnostics, Inc.). Quinolone derivatives. EP 1317442, EP 1650203, EP 1849782, JP 2004509112, US 2002107392, US 6605617, WO 2002022598. |
【2】
Harrison, S.D., Shafer, C.M., Pecchi, S. et al. (Novartis Vaccines and Diagnostics, Inc.). Benzimidazole quinolines and uses thereof. EP 1539754, JP 2006503919, JP 2011162563, US 200409235, US 2013018058, WO 2004018419. |
【3】
Renhowe, P.A., Pecchi, S., Machajewski, T.D. (Novartis Vaccines and Diagnostics, Inc.). Quinolone derivatives. JP 2005527587, US 2003028018, WO 2003087095. |
【4】
Cai, S., Chou, J., Harwood, E., Machajewski, T.D., Ryckman, D., Shang, X., Zhu, S. (Novartis Vaccines and Diagnostics, Inc.). Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties. CN 102225926, EP 1699421, JP 2007522098, JP 2011042687, WO 2005046589. |
【5】
Renhowe, P.A., Pecchi, S., Shafer, C.M. et al. Design, structure-activity relationships and in vivo characterization of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A novel class of receptor tyrosine kinase inhibitors. J Med Chem 2009, 52(2): 278-92. |
【6】
Calvin, G., Harwood, E., Ryckman, D., Zhu, S. (Novartis AG). Methods for synthesizing heterocyclic compounds. EP 1888556, EP 2465857, JP 2008540675, US 2011046376, US 8222413, WO 2006125130. |
【7】
Okhamafe, A., Chou, J., Gullapalli, R., Harwood, E., Ryckman, D., Zhu, S.,Shang, X. (Novartis Corp.). Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactic acid salts. CN 102070614, EP 1904480, EP 2266974, EP 2270000, JP 200854289, US 2011178097, US 2012208825, WO 2006127926. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IIa) |
67969 |
5-fluoro-2-nitroaniline |
2369-11-1 |
C6H5FN2O2 |
详情 | 详情
|
(IIb) |
15709 |
5-chloro-2-nitrophenylamine; 5-chloro-2-nitroaniline
|
1635-61-6 |
C6H5ClN2O2 |
详情 | 详情
|
(I) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(III) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(IV) |
67970 |
5-(4-methylpiperazin-1-yl)-2-nitroaniline |
|
C11H16N4O2 |
详情 | 详情
|
(V) |
31430 |
2-amino-4-(4-methyl-1-piperazinyl)phenylamine; 4-(4-methyl-1-piperazinyl)-1,2-benzenediamine
|
54998-08-2 |
C11H18N4 |
详情 | 详情
|
(VI) |
67971 |
ethyl 3-ethoxy-3-iminopropionate hydrochloride |
2318-25-4 |
C7H13NO3.HCl |
详情 | 详情
|
(VII) |
67972 |
ethyl 2-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)acetate |
|
C16H22N4O2 |
详情 | 详情
|
(VIII) |
13857 |
5-Amino-2-fluorobenzonitrile; 2-Amino-6-fluorobenzonitrile
|
77326-36-4 |
C7H5FN2 |
详情 | 详情
|
(IX) |
67973 |
4-amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one |
405169-16-6 |
C21H21FN6O |
详情 | 详情
|